Related Research Articles
Ellen S. Vitetta is the director of the Cancer Immunobiology Center at the University of Texas Southwestern Medical Center in Dallas.
Nicholas P. Restifo is an American immunologist,physician and educator in cancer immunotherapy. Until July 2019,he was a tenured senior investigator in the intramural National Cancer Institute of the National Institutes of Health at Bethesda,Maryland. Nicholas was an executive vice president of research at Lyell based in San Francisco.
Mark Irwin Greene is a professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania.
James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
George C. Prendergast is an American biomedical scientist. His research has focused on cancer pathobiology and immunology. Since 2004,he has been the President and CEO of Lankenau Institute for Medical Research,a cancer-focused research center in the U.S. He is also the co-director of the Program in Cancer Cell Biology &Signaling at the Sidney Kimmel Cancer Center,Thomas Jefferson University.
Hua Eleanor Yu is the inaugural Billy and Audrey L. Wilder Professor in tumor immunotherapy at the Beckman Research Institute of the City of Hope National Medical Center in Duarte,California. In addition,she co-leads the Cancer Immunotherapeutics Program at the City of Hope cancer center,with Peter P. Lee. Yu's laboratory was the first to identify STAT3,a protein that helps to protect tumor cells from the immune system. Her group is developing possible drug treatments using CpG-Stat3 siRNA to attack tumor cells in mice and humans.
Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.
Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.
David A. Scheinberg is an American physician,scientist,drug developer,and entrepreneur,who is currently Vincent Astor Chair,and Chairman of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center (MSK). He is a pioneer and inventor of targeted alpha particle therapies and alpha particle generators for use in patients with cancer.
Padmanee Sharma is an immunologist and oncologist at the University of Texas MD Anderson Cancer Center in Houston,Texas. She holds the position of professor of genitourinary medical oncology and immunology in the Division of Cancer Medicine where she specializes in renal,prostate,and bladder cancers.
Miram Merad is a French-Algerian professor in Cancer immunology and the Director of the Marc and Jennifer Lipschultz Precision Immunology Institute (PrIISM) at the Icahn School of Medicine at Mount Sinai (ISMMS) in New York,NY. She is the corecipient of the 2018 William B. Coley Award for Distinguished Research in Basic Immunology and a member of the United States National Academy of Sciences and the National Academy of Medicine.
Pamela Sumiko Ohashi,PhD,FRSC is a Canadian medical researcher. She is co-director of the Campbell Family Institute for Breast Cancer Research,director of the Cancer Immune Therapy Program at the Princess Margaret Cancer Centre and a professor at the University of Toronto.
Scott A. Waldman is an MD and biomedical scientist at Sidney Kimmel Medical College of Thomas Jefferson University,where he is the Samuel M.V. Hamilton Professor of Medicine,and also tenured professor and chair of the Department of Pharmacology &Experimental Therapeutics. He is author of a pharmacology textbook,and former chief editor of Clinical Pharmacology &Therapeutics. He is known for his work in atrial natriuretic factor intracellular signaling through guanylate cyclase (GC),and the relation of Guanylyl cyclase C (GC-C) to the pathogenesis of colorectal cancer. Also for his hypotheses concerning the roles of intestinal paracrine hormones in satiety,obesity and cancer risk. Waldman also holds a concurrent position as adjunct professor at the University of Delaware,School of Health Sciences.
Maria G. Castro is an Argentine neuroscientist. She is the R. C. Schneider Collegiate Professor of Neurosurgery and a Professor of Cell and Developmental Biology at the University of Michigan Medical School. Her research focuses on cancer immunology and gliomas.
Antoni Ribas is a Spanish American physician–scientist. He is a Professor of Medicine,Surgery,and Molecular and Medical Pharmacology at the University of California,Los Angeles (UCLA) and Director of the Tumor Immunology Program at the Jonsson Comprehensive Cancer Center. Ribas served as president of the American Association for Cancer Research (AACR) in 2021–2022.
George Coukos is a physician-scientist in tumor immunology,professor and director of the Ludwig Cancer Research Lausanne Branch and director of the Department of oncology UNIL-CHUV of the University of Lausanne and the Lausanne University Hospital in Lausanne,Switzerland. He is known for his work on the mechanisms by which tumors suppress anti-cancer immune responses,and the role of the tumor vasculature in that suppression. In addition to his work in ovarian cancer,the combinatorial immune therapies proposed by Professor Coukos have been successfully tested and approved for lung,liver and kidney cancers.
Philip Greenberg is a professor of medicine,oncology,and immunology at the University of Washington and head of program in immunology at the Fred Hutchinson Cancer Research Center. His research is centered around T cell biology and therapeutic cell therapies. He is a co-founder of Juno Therapeutics.
Cornelis Joseph Maria Melief is a immunologuist specialising in cancer immunology and immunotherapy,with a focus on therapeutic cancer vaccines. He is emeritus Professor,former head of the Department of Immunohematology and Blood Transfusion at the Leiden University Medical Center,and Chief Scientific Officer at ISA Therapeutics in Netherlands. He is known for his work in the field of cancer immunology,devising new cancer therapies based on the activation of the patient's own immune system.
Dario Angelo Alberto Vignali is a British/American immunologist and an academic. He is the Chair of the Immunology Department at the University of Pittsburgh,where he is also a Distinguished Professor and the Frank Dixon Chair for Cancer Immunology. He is also associate director for Scientific Strategy and Co-Leader of the Cancer Immunology and Immunotherapy Program at the UPMC Hillman Cancer Center.
References
- ↑ "Wherry Lab". The Trustees of the University of Pennsylvania. Retrieved 2020-12-13.
- ↑ "E. John Wherry, PhD". The Trustees of the University of Pennsylvania. Retrieved December 13, 2020.
- ↑ Wherry, PhD (April 25, 2013). "Distinguished Alumni Award Lecture". Jefferson Digital Commons. Thomas Jefferson University. Retrieved December 13, 2020.
- ↑ "2000 Commencement for Jefferson Medical College and College of Graduate Studies". Jefferson Digital Commons. Thomas Jefferson University. June 9, 2000. Retrieved December 13, 2020.
- ↑ "Molecular basis of t cell exhaustion: Insights for immunotherapy". Cell Symposia: Cancer, Inflammation, and Immunity. Elsevier Inc. 2017. Retrieved December 13, 2020.
- ↑ "Molecular basis of t cell exhaustion: Insights for immunotherapy". Cell Symposia: Cancer, Inflammation, and Immunity. Elsevier Inc. 2017. Retrieved December 13, 2020.
- ↑ "E. John Wherry: Richard and Barbara Schiffrin President's Distinguished Professor". University of Pennsylvania Almanac. The University of Pennsylvania Almanac. January 10, 2017. Retrieved December 13, 2020.
- ↑ "Immunologist Named Chair of Systems Pharmacology". Penn Medicine News. Penn Medicine. July 23, 2018. Retrieved December 13, 2020.
- ↑ Jameson, J. Larry (June 26, 2018). "Appointment of E. John Wherry, PhD, as Chair of the Department of Systems Pharmacology and Translational Therapeutics". Perelman School of Medicine. Retrieved December 13, 2020.
- ↑ "Stand Up To Cancer Encourages "Innovation in Collaboration" through Grants to Research Teams". Stand Up to Cancer. Entertainment Industry Foundation. March 28, 2018. Retrieved December 13, 2020.
- ↑ "Frederick W. Alt Award". Cancer Research Institute . Retrieved December 13, 2020.
- ↑ "The World's Most Influential Scientific Minds 2014" (PDF). Thomson Reuters . Reuters/Tony Gentile. April 2014. Retrieved December 13, 2020.
- ↑ Wherry, PhD (April 25, 2013). "Distinguished Alumni Award Lecture". Jefferson Digital Commons. Thomas Jefferson University. Retrieved December 13, 2020.
- ↑ "Molecular basis of t cell exhaustion: Insights for immunotherapy". Cell Symposia: Cancer, Inflammation, and Immunity. Elsevier Inc. 2017. Retrieved December 13, 2020.
- ↑ Kirk, Margaret O. (2006). "Preparing for the next flu pandemic--manmade or natural" (PDF). Summer 2006 FOCUS. The Wistar Institute. Retrieved December 13, 2020.
